Compare RYTM & MHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYTM | MHK |
|---|---|---|
| Founded | 2008 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 6.2B |
| IPO Year | 2017 | 1995 |
| Metric | RYTM | MHK |
|---|---|---|
| Price | $97.07 | $129.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | ★ $131.14 | $126.10 |
| AVG Volume (30 Days) | 421.1K | ★ 860.2K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.34 | N/A |
| EPS | N/A | ★ 5.11 |
| Revenue | ★ N/A | N/A |
| Revenue This Year | $55.34 | $3.38 |
| Revenue Next Year | $86.06 | $3.09 |
| P/E Ratio | ★ N/A | $24.81 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $74.50 | $92.99 |
| 52 Week High | $122.20 | $140.30 |
| Indicator | RYTM | MHK |
|---|---|---|
| Relative Strength Index (RSI) | 40.64 | 50.75 |
| Support Level | $99.14 | $106.01 |
| Resistance Level | $113.04 | $134.45 |
| Average True Range (ATR) | 3.98 | 3.73 |
| MACD | -0.78 | -0.99 |
| Stochastic Oscillator | 19.75 | 52.21 |
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.
Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Global Ceramic designs, manufactures, sources, distributes and markets a broad line of ceramic, porcelain and natural stone tile products used for floor and wall applications in residential and commercial channels for both remodeling and new construction. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.